Project information

Excellence in research and development of non-coding RNA DIAGnostics in ONcology (RNADIAGON)

Investor logo
Project Identification
Project Period
2/2019 - 1/2023
Investor / Pogramme / Project type
European Union
MU Faculty or unit
Central European Institute of Technology
Cooperating Organization
Universita degli studi di Ferrara (BBM-UF)
BioVendor - Laboratorní medicína, a.s.
Medical University of Graz
University Hospital Hamburg-Eppendorf
University of Medicine and Pharmacy Iuliu Haţieganu Cluj-Napoca
The University of Texas MD Anderson Cancer Center

Project RNADIAGON aims at development of personal skills and knowledge of early-stage and experienced researchers working in the field of non-coding RNA diagnostics in oncology from 5 European (EU) academic centers (Masaryk University, CEITEC, Czech Republic; University Medical Center Hamburg-Eppendorf, Germany; Iuliu Hatieganu University of Medicine and Pharmacy, Romania; University of Ferrara, Italy; Medical University of Graz, Austria) through their (i) long-term stays at the US research center of excellence (MD Anderson Cancer Center, University of Texas, USA) and (ii) traineeships at the education center and manufacturing facilities of industrial partner (BioVendor, Inc.) developing certified (CE IVD) diagnostics, who will work on the development of a new non-coding RNA diagnostic kit in colorectal cancer adopted here as a model project. This research and innovation staff exchange will increase the scientific excellence and quality of related research in the participating EU research institutions, and enable the dissemination of new technologies and approaches related to this field among other EU research institution as well as interested public.


Total number of publications: 7

You are running an old browser version. We recommend updating your browser to its latest version.

More info